We are live on ! Find out more
BLAM

Bourne Lent Asset Management Portfolio holdings

AUM $289M
1-Year Est. Return 30.86%
This Fund
S&P 500
This Quarter Est. Return
+2.44%
1 Year Est. Return
+30.86%
3 Year Est. Return
+76.09%
5 Year Est. Return
+95.46%
10 Year Est. Return
+670.42%
AUM
$209M
AUM Growth
-$111K
Cap. Flow
-$4.23M
Cap. Flow %
-2.03%
Top 10 Hldgs %
77.78%
Holding
58
New
2
Increased
2
Reduced
27
Closed
1

Top Buys

Rank Stock Value
1
PACB icon
Pacific Biosciences
PACB
+$593K
2
ILMN icon
Illumina
ILMN
+$273K
3
WU icon
Western Union
WU
+$216K
4
INTU icon
Intuit
INTU
+$550

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$1.94M
2
CELG
Celgene Corp
CELG
+$670K
3
ADBE icon
Adobe
ADBE
+$505K
4
AAPL icon
Apple
AAPL
+$450K
5
CSCO icon
Cisco
CSCO
+$254K

Sector Composition

Rank Sector Weight
1 Healthcare 40.73%
2 Technology 36.19%
3 Communication Services 9.27%
4 Consumer Discretionary 4%
5 Industrials 3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEG icon
26
Public Service Enterprise Group
PEG
$37.6B
$939K 0.45%
15,122
VZ icon
27
Verizon
VZ
$193B
$914K 0.44%
15,150
PEP icon
28
PepsiCo
PEP
$189B
$771K 0.37%
5,625
BSX icon
29
Boston Scientific
BSX
$69.2B
$724K 0.35%
17,789
INTC icon
30
Intel
INTC
$510B
$664K 0.32%
12,890
LLY icon
31
Eli Lilly
LLY
$1.04T
$587K 0.28%
5,253
MRK icon
32
Merck
MRK
$317B
$561K 0.27%
6,987
BA icon
33
Boeing
BA
$190B
$543K 0.26%
1,428
-100
-7% -$35.7K
CNP icon
34
CenterPoint Energy
CNP
$26.8B
$521K 0.25%
17,266
LHX icon
35
L3Harris
LHX
$53.3B
$469K 0.22%
2,250
-300
-12% -$61.4K
VAR
36
DELISTED
Varian Medical Systems, Inc.
VAR
$404K 0.19%
3,390
LOW icon
37
Lowe's Companies
LOW
$123B
$385K 0.18%
3,500
MCHP icon
38
Microchip Technology
MCHP
$42.2B
$382K 0.18%
8,230
-300
-4% -$13.6K
BMY icon
39
Bristol-Myers Squibb
BMY
$130B
$376K 0.18%
7,420
-400
-5% -$18.8K
SLB icon
40
SLB Ltd
SLB
$74.1B
$376K 0.18%
11,000
-400
-4% -$14.6K
EOG icon
41
EOG Resources
EOG
$71.5B
$360K 0.17%
4,851
HD icon
42
Home Depot
HD
$352B
$336K 0.16%
1,450
SYK icon
43
Stryker
SYK
$129B
$324K 0.16%
1,500
CTSH icon
44
Cognizant
CTSH
$25.1B
$319K 0.15%
5,300
BNY
45
Bank of New York Mellon
BNY
$108B
$316K 0.15%
7,000
XOM icon
46
ExxonMobil
XOM
$628B
$316K 0.15%
4,470
IBM icon
47
IBM
IBM
$222B
$313K 0.15%
2,252
-157
-7% -$21.2K
PG icon
48
Procter & Gamble
PG
$342B
$285K 0.14%
2,291
HRL icon
49
Hormel Foods
HRL
$13.9B
$275K 0.13%
6,295
-1,150
-15% -$48.3K
ILMN icon
50
Illumina
ILMN
$30.2B
$274K 0.13%
+925
New +$273K

Similar funds

Bourne Lent Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, Bourne Lent Asset Management held 58 positions worth $209M, down 0.05% from $209M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Bourne Lent Asset Management's Q3 2019 filing shows 2 new, 2 increased, 27 reduced and 1 closed positions. Its largest new stake was Illumina: 925 shares worth $274K. The largest sale was Idexx Laboratories, an estimated $1.94M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 41% a quarter earlier, followed by Technology and Communication Services.

  • Bourne Lent Asset Management's largest Q3 2019 buy was Illumina: 925 shares worth $274K.
  • Bourne Lent Asset Management added most to Pacific Biosciences in Q3 2019, an estimated $593K increase.
  • Bourne Lent Asset Management's biggest Q3 2019 reduction was Idexx Laboratories, cutting an estimated $1.94M.
  • Bourne Lent Asset Management fully exited Rio Tinto in Q3 2019, selling an estimated $212K.
  • Bourne Lent Asset Management's ten largest holdings make up 78% of its $209M portfolio in Q3 2019.
  • Bourne Lent Asset Management opened 2 new positions and closed 1 in Q3 2019.
  • Bourne Lent Asset Management's portfolio value fell 0.05% quarter-over-quarter to $209M.

Based on Bourne Lent Asset Management's 13F filing for Q3 2019, filed 24 Oct 2019.